Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 77-26-9
Drug Levels and Effects
Summary of Use during Lactation
Butalbital in breastmilk has caused poor feeding and vomiting in one infant. Other agents are preferred, especially while nursing a newborn or preterm infant. If butalbital is used, monitor the infant for sedation, poor feeding and poor weight gain.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. A 7-day-old breastfed infant's urine was qualitatively positive for barbiturate after his mother took a combination of butalbital 50 mg with acetaminophen 325 mg and caffeine 50 mg every 6 hours for 24 hours.[1]
Effects in Breastfed Infants
The mother of a newborn took a product containing acetaminophen 325 mg, butalbital 50 mg, and caffeine 40 mg every 6 hours for 24 hours for a spinal headache, with the last dose a day prior to presentation at the emergency department. Her 7-day-old infant had a history of 1 to 2 days of poor feeding, lethargy and vomiting. The infant was somnolent, lethargic, and demonstrating diminished reflexes. The urine was qualitatively positive for barbiturate and had also had 1 mg/L of caffeine 15 hours after hospital admission. The infant's symptoms resolved within 24 hours. The symptoms were probably caused by butalbital.[1]
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Vohra V, Marraffa JM. Maternal use of acetaminophen-butalbital-caffeine product resulting in neonate butalbital exposure through breast milk. Clin Toxicol 2019;57:549. [Abstract]. doi: 10.1080/15563650.2019.1598646. [CrossRef]
Substance Identification
Substance Name
Butalbital
CAS Registry Number
77-26-9
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Secobarbital.[Drugs and Lactation Database (...]Review Secobarbital.. Drugs and Lactation Database (LactMed®). 2006
- Review Butabarbital.[Drugs and Lactation Database (...]Review Butabarbital.. Drugs and Lactation Database (LactMed®). 2006
- Review Pentobarbital.[Drugs and Lactation Database (...]Review Pentobarbital.. Drugs and Lactation Database (LactMed®). 2006
- Review Phenobarbital.[Drugs and Lactation Database (...]Review Phenobarbital.. Drugs and Lactation Database (LactMed®). 2006
- Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog.[Drug Metab Dispos. 1980]Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog.Dain JG, Bhuta SI, Coombs RA, Talbot KC, Dugger HA. Drug Metab Dispos. 1980 Jul-Aug; 8(4):247-52.
- Butalbital - Drugs and Lactation Database (LactMed®)Butalbital - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...